| DAY 1 | |
| Time | Session |
| 09.00-09.15 | Introduction |
| 09.15-10.00 | Keynote Lecture Roger Nicoll, UCSF, CA, USA |
| 10.00-10.30 | COFFEE BREAK |
| 10.30-12.30 | Session One: Synaptic dysfunction in Parkinson's disease |
| 10.30-11.00 | Bernardo Sabatini, Harvard Medical School, MA, USA |
| 11.00-11.30 | Robert Edwards, UCSF, CA, USA |
| 11.30-12.00 | D James Surmeier, Northwestern University Medical School, IL, USA |
| 12.00-12.15 | Short talk |
| 12.15-12.30 | Short talk |
| 12.30-13.30 | LUNCH |
| 13.30-15.30 | Session Two: Synaptic dysfunction in Alzheimer’s disease |
| 13.30-14.00 | John Isaac, Eli Lilly and Company, UK |
| 14.00-14.30 | Andy Randall, Universities of Exeter and Bristol, UK |
| 14.30-15.00 | Jie Shen, Harvard Medical School, MA, USA |
| 15.00-15.15 | Short talk |
| 15.15-15.30 | Short talk |
| 15.30-16.00 | COFFEE BREAK |
| 16.00-18.30 | Session Three: Protein misfolding, autophagy and synaptic dysfunction in neurodegenerative diseases |
| 16.00-16.30 | Giovanna Mallucci, University of Leicester, UK |
| 16.30-17.00 | Ted Dawson, Johns Hopkins University School of Medicine, MD, USA |
| 17.00-17.30 | Chris Henderson, Columbia University, NY, USA |
| 18.00-18.15 | Short talk |
| 18.15-18.30 | Short talk |
| 18.30-21.00 | POSTER SESSION |
| DAY 2 | |
| Time | Session |
| 08.00-10.00 | |
| 08.00-08.30 | Karen E Duff, Columbia University, NY, USA |
| 08.30-09.00 | Amy Pooler, King's College London, UK |
| 09.00-09.30 | Markus Tolnay, Universitätsspital Basel, Switzerland |
| 09.30-09.45 | Short talk |
| 09.45-10.00 | Short talk |
| 10.00-10.30 | COFFEE BREAK |
| 10.30-12.30 | Session Five: Synaptic integration of iPS-derived neurons and their use in neurodegenerative disease |
| 10.30-11.00 | Richard Wade-Martins, University of Oxford, UK |
| 11.00-11.30 | Dr Clive Svendsen, Cedars Sinai Medical Institute, CA, USA |
| 11.30-12.00 | Thomas C Sudhof, Stanford University, CA, USA |
| 12.00-12.15 | Short talk |
| 12.15-12.30 | Short talk |
| 12.30-13.30 | LUNCH |
| 13.30-16.00 | Session Six: Genetic and mitochondrial determinants of synaptic dysfunction in neurodegenerative disease |
| 13.30-14.00 | Sabine Hilfiker, Institute of Parasitology and Biomedicine, Granada, Spain |
| 14.00-14.30 | Reddy Hemachandra, OHSU, OR, USA |
| 14.30-15.00 | Thomas Schwarz, Harvard University |
| 15.00-15.15 | Short talk |
| 15.15-15.30 | Short talk |
| 15.30-16.00 | COFFEE BREAK |
| 16.00-18.00 | Session Seven: Targeting synapses with therapeutics in neurodegenerative disease |
| 16.00-16.30 | Morgan Sheng, Genentech, San Francisco, CA, USA |
| 16.30-17.00 | Stephen Traynelis, Emory University School of Medicine, GA, USA |
| 17.00-17.30 | Jeffrey Conn, Vanderbilt Centre for Neuroscience Drug Discovery, TN, USA |
| 17.45-18.00 | Targeting synapses with therapeutics in neurodegenerative disease |
| 18.00-18.45 | Keynote Lecture |